Naohisa Uchimura

Kurume, 8300011, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 95 publications

Comparison of next-morning residual effects by bedtime administration of vornorexant and zopiclone in healthy older participants: postural stability, neuropsychological functions, and subjective sleepiness in a randomized clinical study.

Comparison of next-morning residual effects by bedtime administration of vornorexant and zopiclone in healthy older participants: postural stability, neuropsychological functions, and subjective sleepiness in a randomized clinical study.

Journal: Psychopharmacology

Published: November 28, 2025

Effects of daridorexant on sleep architecture in Japanese patients with insomnia disorder: analysis of a phase II randomized controlled trial.

Effects of daridorexant on sleep architecture in Japanese patients with insomnia disorder: analysis of a phase II randomized controlled trial.

Journal: Sleep and biological rhythms

Published: November 12, 2025

Efficacy and safety of vornorexant in Japanese patients with insomnia: a randomized, placebo-controlled phase 3 pivotal study.

Efficacy and safety of vornorexant in Japanese patients with insomnia: a randomized, placebo-controlled phase 3 pivotal study.

Journal: Sleep

Published: May 30, 2025

Sleep Spindle Measures in Japanese Patients With Drug-Naïve Schizophrenia Using Standard Polysomnography Data: A Retrospective Pilot Study.

Sleep Spindle Measures in Japanese Patients With Drug-Naïve Schizophrenia Using Standard Polysomnography Data: A Retrospective Pilot Study.

Journal: Early intervention in psychiatry

Published: May 09, 2025

Self-reported sleep variables, sleep quality, and quality of life assessment in transition to lemborexant in patients with Insomnia: the multicenter, open-label SOMNUS study.

Self-reported sleep variables, sleep quality, and quality of life assessment in transition to lemborexant in patients with Insomnia: the multicenter, open-label SOMNUS study.

Journal: Sleep medicine: X

Published: April 25, 2025

Assessment of sleep phase, quality, and quantity: the development and validation of the 3-dimensional sleep scale (3DSS).

Assessment of sleep phase, quality, and quantity: the development and validation of the 3-dimensional sleep scale (3DSS).

Journal: Sleep and biological rhythms

Published: January 29, 2025

Development, reliability, and validity of the quality of life scale for insomnia: a health-related quality of life instrument for insomnia.

Development, reliability, and validity of the quality of life scale for insomnia: a health-related quality of life instrument for insomnia.

Journal: Frontiers in psychiatry

Published: December 02, 2024

Long-term safety and efficacy of daridorexant in Japanese patients with insomnia disorder.

Long-term safety and efficacy of daridorexant in Japanese patients with insomnia disorder.

Journal: Sleep medicine

Published: June 11, 2024

Daridorexant in Japanese patients with insomnia disorder: A phase 3, randomized, double-blind, placebo-controlled study.

Daridorexant in Japanese patients with insomnia disorder: A phase 3, randomized, double-blind, placebo-controlled study.

Journal: Sleep medicine

Published: June 11, 2024

Altered Functional Connectivity during Mild Transient Respiratory Impairment Induced by a Resistive Load.

Altered Functional Connectivity during Mild Transient Respiratory Impairment Induced by a Resistive Load.

Journal: Journal of clinical medicine

Published: March 19, 2024

A randomized, double-blind, placebo-controlled, crossover study of respiratory safety of lemborexant in moderate to severe obstructive sleep apnea.

A randomized, double-blind, placebo-controlled, crossover study of respiratory safety of lemborexant in moderate to severe obstructive sleep apnea.

Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

Published: September 07, 2023

Factors associated with the long-term use of benzodiazepine receptor agonists as hypnotics among patients with major depressive disorder and comorbid insomnia.

Factors associated with the long-term use of benzodiazepine receptor agonists as hypnotics among patients with major depressive disorder and comorbid insomnia.

Journal: Journal of psychiatric research

Published: August 26, 2023

Showing 1-12 of 95

Last Updated: 09/26/2026